Abstract

REYES, Diana Ávila; BERNAI, Andrés  and  GOMEZ, José Fernando. Aquapheresis: ¿works?. Rev. colom. nefrol. [online]. 2020, vol.7, n.1, pp.84-96.  Epub Dec 11, 2020. ISSN 2500-5006.  https://doi.org/10.22265/acnef.7.1.365.

The therapy of Aquapheresis has been studied as a therapeutic tool for patients with volume overload refractory to treatment with ASA diuretics, whose main objective is to mitigate the clinical impact of the same in patients with decompensated heart failure and cardiorenal syndrome, recognizing positive cumulative balances in critically ill patients as a factor regardless of mortality. A search was made in the main scientific databases for review articles, and studies that included the Acuapheresis strategy. Bibliographic references were found in databases from 2005 to 2017. Aquapheresis therapy is a patented ultrafiltration therapy aimed at improving refractory overload in patients with congestive heart failure. There are gaps in knowledge regarding cost-effectiveness therapy, real adverse adverse event relationships attributable to it and candidates will benefit, and we believe that more quality studies are required to reach solid conclusions. So far there is no compelling evidence to support Aquapheresis therapy to implement its routine and routine use of the ICU.

Keywords : Ultrafiltration; heart failure; fluid overload; cardiorenal syndrome; acute kidney injury; dialysis; extracorporeal; critical care.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )